The FDA has provided an update on actions the agency has taken, and those underway, to strengthen the safety and resiliency of the supply of infant formula, including a progress report on recommendations in the FDA’s Evaluation of the Infant Formula Response and strategies to prevent Cronobacter illnesses associated with infant formula.